XML 13 R3.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Revenues:        
Product sales, net $ 13,081 $ 16,226 $ 24,103 $ 29,521
License fee and other collaboration revenues 2,288 2,529 4,615 2,529
Royalties 33 72 69 83
Total revenues 15,402 18,827 28,787 32,133
Costs and expenses:        
Cost of product sales 2,082 1,884 5,123 2,894
Research and development expenses 16,695 14,784 30,261 27,152
Selling, general and administrative expenses 16,826 24,004 36,460 47,460
Total costs and expenses 35,603 40,672 71,844 77,506
Other income (expense):        
Interest and dividend income, net 452 404 1,012 875
(Losses) gains on investments, net (209) 794 (208) 798
Fair value adjustment of settlement rights   (788)   (788)
Total other income (expense) 243 410 804 885
Net loss before income taxes (19,958) (21,435) (42,253) (44,488)
Income tax benefit 396 111 396 111
Net loss $ (19,562) $ (21,324) $ (41,857) $ (44,377)
Net loss per share:        
Basic and diluted (in dollars per share) $ (0.92) $ (1.01) $ (1.98) $ (2.16)
Weighted average shares outstanding used to compute net loss per share:        
Basic (in shares) 21,167 21,017 21,156 20,504
Diluted (in shares) 21,167 21,017 21,156 20,504